APA

Hummers L. K., Dugowson C. E., Dechow F. J., Wise R. A., Gregory J., Michalek J., Yenokyan G., McGready J. & Wigley F. M. (20140120). A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. : Annals of the rheumatic diseases.

Chicago

Hummers Laura K, Dugowson Carin E, Dechow Frederick J, Wise Robert A, Gregory Jeffrey, Michalek Joel, Yenokyan Gayane, McGready John and Wigley Fredrick M. 20140120. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. : Annals of the rheumatic diseases.

Harvard

Hummers L. K., Dugowson C. E., Dechow F. J., Wise R. A., Gregory J., Michalek J., Yenokyan G., McGready J. and Wigley F. M. (20140120). A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. : Annals of the rheumatic diseases.

MLA

Hummers Laura K, Dugowson Carin E, Dechow Frederick J, Wise Robert A, Gregory Jeffrey, Michalek Joel, Yenokyan Gayane, McGready John and Wigley Fredrick M. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. : Annals of the rheumatic diseases. 20140120.